• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Is there a Causal Link between Vitamin D and Gestational Hypertension / Preeclampsia?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Vitamin D, 1,25-dihydroxyvitamin D3 (Vitamin D) can suppress renin biosynthesis and regulate implantation
    • Therefore, may impact gestational hypertension and/or preeclampsia   
  • Previous literature on the relationship between low Vitamin D concentration and gestational hypertension/preeclampsia is inconclusive 
  •  ‘Mendelian randomization’ is a technique that assesses genetic variants that impact pathways  
    • Genetic variants are random events at the time of conception, not likely to be impacted by bias
  • Magnus et al. (BMJ 2018) sought to determine whether low Vitamin D concentration has a causal effect on gestational hypertension or pre-eclampsia using knowledge of genetic variants that impact Vitamin D pathways

METHODS: 

  • One and two sample mendelian randomization analysis  
    • Such analyses can be used to determine possible causal relationships  
  • ‘One Sample’ mendelian randomization analysis  
    • Assesses the genetic variants along the vitamin D pathway and outcomes (gestational hypertension and preeclampsia) in the same individual 
  • ‘Two Sample’ mendelian randomization analysis 
    • Results from genome studies are used to determine how the variants impact Vitamin D levels and assess whether variants that result in lower Vitamin D levels are associated with higher risk for gestational hypertension or preeclampsia  
  • Vitamin D levels were measured in serum and plasma, and adjusted based on seasons and categorized based on Endocrine Society recommendations  
    • < 25 nmol/L | 25-49.9 nmol/L | 50-74.9 nmol/L | ≥75 nmol/L 
  • Primary outcomes  
    • Gestational hypertension  
    • Preeclampsia  
  • Definitions of preeclampsia and gestational hypertension were based on International Society for the Study of Hypertension in Pregnancy criteria

RESULTS: 

  • One sample analysis 
    • 7389 women were included  
      • 751 with gestational hypertension  
      • 135 with pre-eclampsia 
  • Two sample analysis  
    • 3388 preeclampsia cases 
    • 6059 controls  

In the conventional multivariable analysis comparing Vit D levels to outcomes  

  • Pre-eclampsia 
    • Vitamin D levels <25 nmol/L compared with ≥75 nmol/L  
      • RR 2.04 (95% CI, 1.02 to 4.07)  
    • Gestational hypertension: No association  

One sample mendelian randomization analysis (using total genetic risk score) 

  • There was no strong evidence for a linear effect (increase or decrease) of Vitamin D on the risk of gestational hypertension or pre-eclampsia 

Two sample mendelian randomization analysis 

  • Preeclampsia: Odds ratio (OR) 0.98 (95% CI, 0.89 to 1.07) per 10% decrease in Vitamin D level 
  • Nor was there evidence of a causal linear effect

CONCLUSION: 

  • The authors did not “find any appreciable evidence of a causal effect of Vitamin D levels less than 75 nmol/L or less than 50 nmol/L on the risk of pre-eclampsia” 
  • These results support the WHO guidance that currently, there is insufficient evidence to warrant vitamin D supplementation to prevent adverse pregnancy outcomes  
  • Future studies are needed with larger number of women and more genetic instruments 
    • RCTs can assess the effect of supplements at particularly critical periods in time (e.g. around conception)

Learn More – Primary Sources: 

Vitamin D and risk of pregnancy related hypertensive disorders: mendelian randomisation study

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Does Vitamin D Intake Decrease the Risk for Gestational Diabetes Mellitus?
Vitamin D Levels: Is There an Association with Livebirth and/or Miscarriage
Are Vitamin D Levels Linked to Preeclampsia and Preterm Birth?
(Cochrane 2016) Vitamin D During Pregnancy and Adverse Pregnancy Outcomes
Does Vitamin D Decrease Risk of Respiratory Infections?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site